| Detected | Trial | Change |
|---|---|---|
| 2026-08-06 | NCT05551858 Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis |
date change Primary completion pushed: 2026-06-30 -> 2030-06-30 |
| 2026-08-06 | NCT05551858 Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis |
date change Completion pushed: 2026-12-31 -> 2031-12-31 |
| 2026-08-05 | NCT07644598 MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With… |
Recruitment opened |
| 2026-07-30 | NCT05896852 Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV |
Trial completed |
| 2026-07-30 | NCT05896852 Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV |
Enrollment reduced: 50 -> 40 participants |
| 2026-07-30 | NCT05896852 Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV |
date change Primary completion moved earlier: 2026-07 -> 2025-06-11 |
| 2026-07-30 | NCT05896852 Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV |
date change Completion moved earlier: 2026-10 -> 2025-06-11 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05482516 | Evaluating Novel Therapies in ctDNA Positive GI Cancers | Colon Adenocarcinoma | Recruiting |
| NCT06290869 | Tobacco Education and Lung Health Study (TEAL) | Smoking Cessation | Recruiting |
| Phase 2 | |||
| NCT04865887 | Pembrolizumab and Lenvatinib in Advanced Cervical Cancer | Cervical Cancer | Recruiting |
| NCT06248515 | A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial… | Thymoma | Recruiting |
| NCT04499053 | Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients… | Carcinoma, Non-Small Cell Lung | Recruiting |
| NCT07644598 | MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With… | Prostate Cancer | Recruiting |
| NCT06449313 | Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell… | Non-small Cell Lung Cancer Stage III | Recruiting |
| NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | Advanced Biliary Tract Cancer | Active, Not Recruiting |
| NCT04958811 | Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced… | Non-squamous Non-small-cell Lung Cancer | Active, Not Recruiting |
| NCT05558982 | BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | Metastatic Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |
| NCT04091750 | Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma | Melanoma | Active, Not Recruiting |
| NCT05479045 | A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic… | Ovarian Cancer Stage IV | Not Yet Recruiting |
| NCT03467867 | A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT07592767 | RESvEraTrol in Parkinson's Disease (RESET) | Parkinson's Disease | Not Yet Recruiting |
| NCT05827055 | Proglumide and Chemotherapy for Metastatic Pancreatic Cancer | Metastatic Pancreatic Cancer | Active, Not Recruiting |
| NCT07645326 | RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Not Yet Recruiting |
| NCT06227546 | MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer | Extensive-stage Small-cell Lung Cancer | Active, Not Recruiting |
| NCT06015724 | Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05256745 | RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer | Cancer Related Cognitive Decline | Recruiting |
| NCT04990102 | Phase IB/II of CPX-351 for Relapse Prevention in AML | Acute Myeloid Leukemia (AML) in Remission | Recruiting |
| NCT03964532 | TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in… | Breast Cancer | Active, Not Recruiting |
| NCT05551858 | Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis | Safety Issues | Active, Not Recruiting |
| Phase 1 | |||
| NCT05661201 | NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors | Solid Tumor | Recruiting |
| Not specified | |||
| NCT03702907 | DC Longitudinal Study on Aging and Specimen Bank | Alzheimer Disease | Recruiting |
| NCT04258280 | Improving Genetic Counseling for BRCA+ Mothers | Breast Cancer | Recruiting |